Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · May 29, 2023

Successful Tapering of Dupilumab in Patients With Atopic Dermatitis With Low Disease Activity

The British Journal of Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
Successful tapering of dupilumab in atopic dermatitis patients with low disease activity: a large pragmatic daily practice study from the BioDay registry
Br J Dermatol 2023 May 13;[EPub Ahead of Print], LS Spekhorst, CM Boesjes, L Loman, NPA Zuithoff, DS Bakker, E Kamphuis, M Kamsteeg, I Haeck, AJ Oosting, PPM van Lumig, AMT van Lynden-van Nes, RA Tupker, A Flinterman, FM Garritsen, WRH Touwslager, MS de Bruin-Weller, ML Schuttelaar, M de Graaf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading